Isis Pharmaceuticals
- Categories: Biotechnology, Pharmaceutical
- Client: Isis Pharmaceuticals
Website: https://www.isispharm.com/
Dr. Roger Lane was successfully recruited by The Chase Group to join Isis Pharmaceuticals as the new Vice President of Clinical Development in Neurology.
The Chase Group Places VP of Clinical Development and Pharmacovigilance at Marinus Pharmaceuticals
The Chase Group is pleased to continue partnership with Marinus in building their leadership team with the recent placement of the Vice President of Clinical…
The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly
The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice…
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor…
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with…
A Successful Placement at Eisai, Inc.
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board…-
Another Successful Placement by The Chase Group at Marinus Pharmaceuticals
The Chase Group is pleased to announce the successful completion of the Executive Director, Head of Clinical Development Operations search at Marinus Pharmaceuticals. The successful…